The Research Behind Foundayo, Explained Foundayo's FDA approval was supported by the ATTAIN clinical trial program , a large-scale Phase 3 study that evaluated its safety and efficacy in adults with obesity or overweight across two global trials
While data specific to GLP-1 RA discontinuation remain limited, a large-scale prospective study on weight cycling (mean age 63.6 years, at high risk of T2DM) reported that weight regain was typically characterized by an adverse shift in body composition, with FM returning to baseline levels while FFM declined by 1.50 kg (95% CI 0.662.35)
If the diarrhea is severe, persistent, or accompanied by abdominal pain, stop taking it and talk to your doctor immediately
Depending on how well you tolerate that dose, it may be increased every four weeks, eventually reaching doses as high as 12 mg weekly in advanced stages
Let's be blunt: shaking a peptide solution is like putting a delicate silk shirt in a washing machine with rocks
Various studies have found that, among patients with type 2 diabetes, a history of myocardial infarction or stroke, or arteriosclerotic cardiovascular disease, liraglutide use was associated with a lower incidence of cardiovascular disease than in the control group [16]
.png)
